Shinoura et al. showed that adenoviral delivery of FADD adenovirus (Adeno-FADD) potentially induced apoptosis in Fas ligand-resistant U251 glioma cells, suggesting that FADD could be a therapeutic modality for treating gliomas [189]. This evidence concerns the gene FASLG and central nervous system cancer.